It is explicitly not intended for human consumption, diagnostic, or therapeutic applications
This can lead to palpitations, irregular heart rhythms, or even chest pain
Nausea affects approximately 28% of users at the 12mg dose, with diarrhea (24%), constipation (21%), and vomiting (17%) also common
Rodent models show accelerated tendon healing, increased collagen organisation, and improved biomechanical strength under controlled injury conditions
The only ASV identified as Lactococcus mapped to Lactococcus lactis
AOD 9604 + NAD+ Combining AOD 9604 with NAD+ therapy at Perfect B in Doral targets two separate axes of metabolic function: NAD+ addresses cellular energy metabolism, mitochondrial efficiency, and metabolic resilience at the enzymatic level, while AOD 9604 drives fat mobilization from adipose tissue